These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17844936)

  • 21. Public-private health partnerships: a strategy for WHO.
    Buse K; Waxman A
    Bull World Health Organ; 2001; 79(8):748-54. PubMed ID: 11545332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug development.
    Markman M
    Cancer; 2008 May; 112(9):1871-3. PubMed ID: 18318430
    [No Abstract]   [Full Text] [Related]  

  • 23. WHO reforms long overdue, critics say.
    Collier R
    CMAJ; 2011 Oct; 183(14):1574-5. PubMed ID: 21896696
    [No Abstract]   [Full Text] [Related]  

  • 24. Your money or your life: a new variation on the Heinz Dilemma.
    Thompson RE
    Physician Exec; 2004; 30(1):58-61. PubMed ID: 14983708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. It's not about the money.
    Rosen CD
    Spine J; 2011 Aug; 11(8):700-2. PubMed ID: 21925413
    [No Abstract]   [Full Text] [Related]  

  • 26. The World Health Organisation. Interview with the director general. Interview by Fiona Godlee.
    Nakajima H
    BMJ; 1995 Mar; 310(6979):583-6. PubMed ID: 7888938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Professional ethics--business ethics.
    Crombie HD
    Conn Med; 2011 May; 75(5):303. PubMed ID: 21678845
    [No Abstract]   [Full Text] [Related]  

  • 28. WHO: the casualties and compromises of renewal.
    Horton R
    Lancet; 2002 May; 359(9317):1605-11. PubMed ID: 12047986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WHO boss faces test of independence.
    Butler D
    Nature; 2006 Nov; 444(7117):250. PubMed ID: 17108922
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world.
    Hale VG; Woo K; Lipton HL
    Health Aff (Millwood); 2005; 24(4):1057-63. PubMed ID: 16012146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The independence of international civil servants during the neoliberal decades: implications of the work stoppage involving 700 staff of the World Health Organization in November 2005.
    Katz A
    Int J Health Serv; 2008; 38(1):161-82. PubMed ID: 18341128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allocating the WHO's resources rationally. One cheer for the who's proposed changes in regional budgets?
    Bevan G
    BMJ; 1998 May; 316(7142):1403-4. PubMed ID: 9572745
    [No Abstract]   [Full Text] [Related]  

  • 33. 'Nice guys, your reps, right?'.
    Kochen MM
    Eur J Gen Pract; 2010 Sep; 16(3):129-30. PubMed ID: 20672872
    [No Abstract]   [Full Text] [Related]  

  • 34. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reform of the World Health Organization.
    Ermakov V
    Lancet; 1996 Jun; 347(9014):1536-7. PubMed ID: 8684109
    [No Abstract]   [Full Text] [Related]  

  • 36. Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.
    Liss H
    Isr Med Assoc J; 2006 Jul; 8(7):451-4. PubMed ID: 16889157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug firms' representatives express concern over WHO's AIDS drug list.
    Kapp C
    Lancet; 2002 Mar; 359(9312):1134. PubMed ID: 11943279
    [No Abstract]   [Full Text] [Related]  

  • 38. WHO's programme on essential drugs. Background, implementation, present state and prospectives.
    Lunde PK
    Dan Med Bull; 1984 Nov; 31 Suppl 1():23-7. PubMed ID: 6518827
    [No Abstract]   [Full Text] [Related]  

  • 39. WHO's HIV/AIDS strategy under the spotlight.
    Kim JY
    Bull World Health Organ; 2004 Jun; 82(6):474-6. PubMed ID: 15356946
    [No Abstract]   [Full Text] [Related]  

  • 40. Is there a bioethicist in your company? Should there be?
    Magnus D
    Drug Discov Today; 2002 Apr; 7(7):385-7. PubMed ID: 11916559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.